The international drug control regime is facing the most profound challenge of its existence. Member states have for some time been experimenting with new responses to the ‘world drug problem’; however, the advent of legally regulated cannabis markets has resulted in a ratcheting up of these challenges to expose the system to new levels of strain. With the 2016 UN General Assembly Special Session (UNGASS) on the world drug problem fast approaching, how will the international community make use of the opportunity it provides for a free and open debate?
This March, our video advocacy team attended the 58th session of the Commission on Narcotic Drugs, the largest drug policy gathering in the world, to find out how governments and NGOs feel about the prospects of drug policy reform. We produced a series of short thematic videos, to give you an overview of the current state of political debate on the burning issues of international drug control.
With the 2016 UNGASS on drugs in one year, it is time to recognize the policy landscape is shifting while tensions within the UN drug control system continue to grow. A slowly increasing number of governments is expressing their frustrations with the current international drug control framework, particularly Mexico and Colombia, countries that are suffering from violence related to drug markets, are calling for reflection and analysis in order to consider new options, some of which include regulatory measures.
China is proposing there should be a worldwide ban on ketamine - the class B drug that can lead to users needing to have their bladders removed. But ketamine is used as an anaesthetic drug in much of Africa, and there are fears further international controls could affect medical usage too.
Just over one year away from the 2016 UNGASS, denying the reality that the drug policy landscape has fundamentally changed and that tensions with the UN drug conventions are occuring, is no longer a credible option. Secretary General Ban Ki-moon urged member states to use the 2016 UNGASS on drugs "to conduct a wide-ranging and open debate that considers all options." TNI calls for a special advisory group that should be tasked with recommending how to better deal with the contentious issues following the 2016 UNGASS, in preparation for the next UN high-level review in 2019.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.
Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.
The most important drug policy event this quarter was undoubtedly the 57th Session of the UN Commission on Narcotic Drugs (CND) in Vienna from 13 to 21 March, the first two days of which were dedicated to a high-level review of the past five years. The winds of drug policy change were clearly felt in the statements made by several Latin American countries – Colombia, Guatemala, Ecuador, Mexico and Uruguay – and some European countries – the Czech Republic, Norway and Switzerland, among others.
The current trend towards legal regulation of the cannabis market has become irreversible and requires an urgent dialogue by UN member states on the best models for protecting people’s health and safety, argues a new report. The question facing the international community today is no longer whether there is a need to revise the UN drug control system, but rather when and how to do it.
In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.
Ahead of the High-Level Segment on the world drug problem to take place on 13th and 14th January 2014, the UNODC Executive Director, Yuri Fedotov, has released his "contributions" to the debate. This 19-page document is, in parts, refreshingly honest about the “unequal” progress that has been made since 2009 (with reductions in supply or demand for some drugs in some places being offset by increases elsewhere), the setbacks and new challenges, and the fact that “the overall magnitude of drug demand has not substantially changed at the global level”.
An internal United Nations draft document leaked last weekend has offered outsiders a rare look at longstanding disagreements between member states over the course of U.N. drug policy. The document, first publicised by The Guardian and obtained by IPS, contains over 100 specific policy recommendations and proposals from member states, many at odds with the status quo on illicit drug eradication and prohibition.
Country delegations to the UN Commission on Narcotic Drugs (CND) don’t usually vote on things… The protocol is that member states reach consensus on language and policy (often meaning that the final language reflects the lowest common denominator). Usually this diplomatic process works and delegates compromise. However, at the most recent inter-sessional meeting of the CND on 5th November, some delegates drew “red lines” and staked out non-negotiable positions on key issues.
Reflections upon this year’s CND are mixed. On the one hand, some states went further than ever before in openly challenging the current regime on the grounds that, after a century, it needs modernising. That the government of Uruguay is currently considering a domestic policy on cannabis that would put it in breach of the Single Convention shows that, in one instance at least, we have moved beyond rhetoric and posturing.
Change is in the air ... But the pace could be quickened a bit. While the international policymaking body on drugs has long been stuck in neutral, there are signs that alternative voices are finally breaking through. This year's UN Commission on Narcotic Drugs featured some progress though its modest advances are only remarkable by comparison to a dismal past.
The year 2012 is particularly fitting to discuss the future of the UN drug control conventions as it marks the 100th anniversary of the first fully-fledged multilateral agreement on drug control held in The Hague. Last year was the 50th anniversary of the legislative bedrock of the current treaty regime: the 1961 UN Single Convention on Narcotic Drugs. These historic moments highlight not only its longevity, but also represent appropriate moments to reflect on the continuing relevance of the existing drug control regime in its entirety for the contemporary era.
Wednesday, March 14, 2012 at 13:00, Mozart Room in the Vienna International Centre (VIC Restaurant - Ground Floor, F Building) invitation only
The year 2012 marks the centenary of the international drug control system and the first instance of a state being moved to denounce formally any of the UN drug control treaties. The 55th session of the Commission on Narcotics Drugs (CND), held in Vienna between 12th and 16th March, therefore looked set to be a fascinating event and did not disappoint. As expected, member states favouring the current regime praised its virtues and ongoing relevance 100 years since The Hague Opium Convention; behaviour that found support in the statements and positions of the United Nations Office on Drugs and Crime (UNODC) and the International Narcotics Control Board (INCB or Board).
Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
15 မတ်လ 2009
This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.